Only Orphans Cote LLC is a pioneering biopharmaceutical company dedicated to developing innovative therapies for orphan diseases and rare disorders. With a focus on addressing unmet medical needs in underserved patient populations, the company leverages cutting-edge research and technology to advance novel treatments. Only Orphans Cote LLC is committed to improving the quality of life for individuals affected by rare diseases through a patient-centric approach that prioritizes safety, efficacy, and accessibility. Their participation at World Orphan Drug Congress USA 2026 underscores their dedication to collaboration, innovation, and advocacy within the orphan drug and rare disease community.